Osimertinib ni iki: Ibikoreshwa, Urutonde rw'imiti, Ingaruka ziterwa n'iyo miti n'ibindi

Osimertinib ni umuti w'indwara ya kanseri ugamije kuvura ubwoko runaka bwa kanseri y'ibihaha. Uyu muti ubarirwa mu cyiciro cy'imiti yitwa tyrosine kinase inhibitors, ikora ibikorwa byo guhagarika poroteyine zihariye zifasha selile za kanseri gukura no gukwirakwira.

Uyu muti wateje impinduka mu kuvura abarwayi bafite kanseri y'ibihaha idafite selile nto (NSCLC) ifite impinduka zihariye za genetike. Uyu muti wagenewe gukora neza kurusha imiti gakondo ya shimi, ukaba ugamije gusa selile za kanseri mugihe muri rusange utera ingaruka nke zikomeye.

Osimertinib ni iki?

Osimertinib ni umuti wa kanseri ufata mu kanwa ugamije impinduka zihariye za genetike muri selile za kanseri y'ibihaha. Ni icyo abaganga bita "icyiciro cya gatatu" cya tyrosine kinase inhibitor, bivuze ko yagenewe gutsinda ubudahangarwa bushobora kuvuka hamwe n'imiti isa n'iyi yashaje.

Uyu muti ukora uhagarika poroteyine yitwa EGFR (epidermal growth factor receptor) yahindutse muri kanseri zimwe na zimwe z'ibihaha. Iyo iyi poroteyine ihagaze, selile za kanseri ntizishobora kubona ibimenyetso bakeneye kugirango bakure kandi biyongere, ibi bifasha kugabanya cyangwa guhagarika ikwirakwiza rya kanseri.

Osimertinib ifatwa nk'ikibahasha rimwe ku munsi, bituma byoroha kurusha imiti myinshi ya kanseri isaba gusura ibitaro kugirango baterwe imiti. Ibi bituma abarwayi benshi bakomeza kuvurwa bari mu rugo mugihe bakomeza gukora imirimo yabo ya buri munsi.

Osimertinib ikoreshwa mu kuvura iki?

Osimertinib ikoreshwa cyane cyane mu kuvura kanseri y'ibihaha idafite selile nto (NSCLC) ifite impinduka zihariye za EGFR. Muganga wawe azagerageza igitambaro cyawe cya kanseri kugirango yemeze ko izi mpinduka zihari mbere yo gutanga uyu muti.

Uyu muti wemewe mu bihe bibiri by'ingenzi. Icya mbere, ukoreshwa nk'umuti wa mbere wo kuvura kanseri y'ibihaha yateye imbere yamenyekanye vuba (NSCLC) ifite impinduka zimwe na zimwe za EGFR. Ibi bivuze ko ushobora kuba umuti wa mbere wa kanseri wakira nyuma yo kumenyekana, aho gutangirana na chimiothérapie.

Icya kabiri, osimertinib ivura NSCLC yateje ubworoherane ku bindi bice bya EGFR inhibitors kandi ifite impinduka zihariye yitwa T790M. Iyi mpinduka ishobora kwigaragaza uko iminsi igenda yiyongera uko selile za kanseri zihinduka mu miti yabanje, kandi osimertinib yateguwe by'umwihariko kugira ngo itsinde ubwo bworoherane.

Uyu muti kandi ukoreshwa iyo kanseri y'ibihaha yateye mu bwonko, kuko ishobora kurenga inzitizi y'amaraso n'ubwonko neza kurusha ubundi buryo bwo kuvura bugamije. Ibi bituma bifitiye akamaro kanini abarwayi kanseri yabo yimukiye mu bwonko.

Osimertinib ikora ite?

Osimertinib ikora ibara ibice bya poroteyine ya EGFR yahindutse ikora nk'ibice byangiritse muri selile za kanseri. Muri selile nzima, poroteyine ya EGFR ifasha kugenzura imikurire isanzwe ya selile, ariko muri selile za kanseri, izi poroteyine zihinduka zikora cyane kandi zigatuma imikurire itagira umupaka.

Bitekereze nk'aho ukuraho pedali y'imodoka yangiritse yashyizwe mu mwanya wo

Osimertinib ifatwa rimwe ku munsi nk'ikibahasha, kandi ugomba kuyifata ku isaha imwe buri munsi kugira ngo urinde urugero rwawo mu mubiri wawe. Urashobora kuyifata hamwe cyangwa utayifatanije n'ibiryo, ariko gerageza kubigira buri gihe kugira ngo bifashe mu gufata neza umuti.

Mimina ikibahasha cyose hamwe n'ikirahure cy'amazi. Ntugasenye, ntukore, cyangwa ucagagure ikibahasha, kuko ibi bishobora kugira ingaruka ku buryo umuti ufashwe kandi bikaba bishobora gutera ingaruka zidakurikiza. Niba ugira ikibazo cyo kumira ibibahasha, ganira n'ikipe yawe y'ubuvuzi ku buryo bwo gufata imiti yawe.

Niba ukeneye gufata umuti unyuze mu tuyunguruzo tw'ibiryo, umuganga wawe ashobora kukwereka uburyo bwo gushonga ikibahasha mu mazi mu buryo bwizewe. Ibi bikwiye gukorwa gusa ukurikije amabwiriza yihariye ava mu ikipe yawe y'ubuvuzi.

Ni ngombwa gufata osimertinib nk'uko byategetswe, kabone n'iyo wumva umeze neza. Imiti ivura kanseri ikora neza iyo ifashwe buri gihe, kandi kureka doze bishobora gutuma selile za kanseri zongera gukura.

Nzamara Igihe Kingana Iki Ndafata Osimertinib?

Muri rusange uzakomeza gufata osimertinib igihe cyose ikora kugira ngo igenzure kanseri yawe kandi ukaba uyihanganira neza. Ibi bishobora kumara amezi cyangwa imyaka, bitewe n'uko kanseri yawe yitwara ku buvuzi.

Muganga wawe azagenzura uko urimo utera imbere binyuze mu masikani n'ibizamini by'amaraso buri gihe kugira ngo arebe uko umuti ukora neza. Ibi bizamini bifasha kumenya niba ukwiye gukomeza gufata uwo muti cyangwa niba hari ibikenewe guhindurwa.

Abantu bamwe bafata osimertinib imyaka myinshi niba ikomeje kugira akamaro. Abandi bashobora gukenera guhindura imiti niba kanseri yabo itangiye kwanga umuti cyangwa niba ingaruka zidakurikiza zikomeje kuba ingorabahizi zo gukemura.

Ntuzigere uhagarika gufata osimertinib mu buryo butunguranye utabanje kuvugana na muganga wawe. N'iyo waba ufite ingaruka zidakurikiza, ikipe yawe y'ubuvuzi akenshi ishobora guhindura gahunda yawe y'ubuvuzi kugira ngo igufashe gukomeza kungukira ku muti mu buryo bwizewe.

Ni Ibihe Bikorwa Bigaragara ku Osimertinib?

Mugihe osimertinib akenshi itera ibikorwa bigaragara bikomeye kurusha imiti gakondo ya chemotherapy, iracyashobora gutera ibimenyetso bitari byiza. Ibikorwa bigaragara byinshi bishobora kugenzurwa neza no gukurikiranwa n’ikipe yawe y’ubuzima.

Ibikorwa bigaragara cyane ushobora guhura nabyo birimo impiswi, uruhu rurashye, uruhu rwumye, impinduka z’inzara, no kunanirwa. Ibi bimenyetso akenshi biragenda bikagenda neza uko umubiri wawe ukimenyereza umuti, kandi ikipe yawe y’ubuzima ishobora gutanga ingamba zo gufasha kubigenzura.

Dore ibikorwa bigaragara cyane abarwayi basanzwe bahura nabyo:

• Impiswi, akenshi zishobora kugenzurwa no guhindura imirire no gufata imiti itagurishwa ku isoko
• Uruhu rurashye n’uruhu rwumye, akenshi bigaragara mu byumweru bike bya mbere by’imiti
• Impinduka ku nzara zawe, harimo koroha cyangwa impinduka mu ibara
• Kunanirwa no kumva urushye kurusha uko bisanzwe
• Kugabanya ubushake bwo kurya no gushobora gutakaza ibiro
• Ibisebe mu kanwa cyangwa stomatitis

Ibi bikorwa bigaragara, nubwo bibangamira, akenshi biba byoroheje kugeza hagati kandi bishobora kugenzurwa no gufashwa. Ikipe yawe y’ubuzima izakorana nawe kugirango igabanye ibi bikorwa kandi igufashe kugumana ubuzima bwawe bwiza.

Hariho kandi ibikorwa bigaragara bitari bike ariko bikomeye bisaba ubufasha bwihuse bw’ubuvuzi. Nubwo ibi bibaho ku barwayi bake, ni ngombwa kubimenya kugirango ushobore gushaka ubufasha vuba niba bibaye ngombwa.

Ibyago bikomeye bisaba ubufasha bwihuse bw’ubuvuzi birimo:

• Ibibazo by'ibihaha, harimo no kubyimba kw'ibihaha (pneumonitis), bishobora gutera guhumeka nabi cyangwa inkorora
• Ibibazo by'umutima, harimo n'imihindukire mu mutima cyangwa igabanuka ry'imikorere y'umutima
• Uruhu rwakomeretse cyane rukwira ahantu hanini ku mubiri wawe
• Ibibazo by'amaso, harimo n'imihindukire mu iyerekwa cyangwa kuribwa cyane kw'amaso
• Ibibazo byo kuvura amaraso, bishobora gutera kubyimba cyangwa kuribwa mu maguru yawe

Niba ubonye kimwe muri ibi bimenyetso bikomeye, vugana n'umuganga wawe ako kanya. Kumenya no kuvura hakiri kare izi ngaruka zishobora gufasha kwirinda ibibazo bikomeye.

Ninde utagomba gufata Osimertinib?

Osimertinib ntabwo ikwiriye kuri buri wese, kandi muganga wawe azasuzuma neza niba ari umuti ukwiriye kuri wowe. Uyu muti ukora gusa ku kanseri zifite impinduka zihariye za EGFR, bityo gupima imiterere ya genetike ni ngombwa mbere yo gutangira kuvurwa.

Ntugomba gufata osimertinib niba ufite allergie kuri uyu muti cyangwa ibikubiye muri wo. Bwira muganga wawe ibyerekeye allergie zose wigeze kugira ku miti, cyane cyane indi miti ivura kanseri cyangwa tyrosine kinase inhibitors.

Abagore batwite ntibagomba gufata osimertinib kuko ishobora kwangiza umwana ukura. Niba uri umugore ufite imyaka yo kubyara, uzakenera gukoresha uburyo bwo kuboneza urubyaro bukora neza mu gihe uvurwa kandi byibuze mu byumweru bitandatu nyuma ya doze yawe ya nyuma.

Abagabo bafata osimertinib bagomba kandi gukoresha uburyo bwo kuboneza urubyaro bukora neza mu gihe bavurwa kandi byibuze mu mezi ane nyuma ya doze ya nyuma, kuko uyu muti ushobora kugira ingaruka ku ntanga kandi bikaba bishobora kwangiza umwana ukura.

Abantu bafite ibibazo by'umutima, ibibazo bikomeye by'impyiko, cyangwa indwara ikomeye y'umwijima bashobora gukenera gukurikiranwa byihariye cyangwa guhindurirwa doze. Muganga wawe azasuzuma amateka yawe yose y'ubuzima kugira ngo amenye niba osimertinib ikwiriye kuri wowe.

Amazina y'ubwoko bwa Osimertinib

Osimertinib izwi cyane ku izina ry'ubucuruzi rya Tagrisso, ikorwa na AstraZeneca. Iri ni ryo zina usanzwe ubona ku icupa ry'imiti yawe no ku ipaki y'imiti.

Mu bihugu bimwe na bimwe, osimertinib ishobora kuboneka ku mazina y'ubucuruzi atandukanye cyangwa nk'umuti rusange. Ariko, Tagrisso iracyari uburyo bw'uyu muti buzwi cyane kandi buboneka ku isi hose.

Buri gihe menya neza ko wakiriye umuti ukwiye ugenzura izina rusange (osimertinib) n'izina ry'ubucuruzi (Tagrisso) hamwe na farumasi. Ibi bifasha kumenya neza ko urimo kubona ubuvuzi bukwiye n'urugero rukwiye.

Uburyo bwo gusimbuza Osimertinib

Niba osimertinib itagukwiriye cyangwa ikaba itagikora neza, hari ubuvuzi butandukanye buboneka ku barwayi ba kanseri y'ibihaha ifite EGFR yahindutse. Muganga wawe azatekereza ku biranga kanseri yawe byihariye n'amateka y'ubuvuzi mugihe agushakira ibindi bisimbura.

Izindi EGFR inhibitors zirimo erlotinib (Tarceva) na afatinib (Gilotrif), akenshi zikoreshwa nk'ubuvuzi bwa mbere. Iyi miti ikora kimwe na osimertinib ariko ishobora kuba ikwiriye neza ku bwoko bumwe na bumwe bwa EGFR mutations cyangwa ibibazo by'abarwayi.

Ku barwayi kanseri yabo yateye imbere ku buvuzi bwinshi bwibanda, ubuvuzi buhuriweho bushobora gushyirwaho. Ibi bishobora kuba birimo osimertinib ihuriweho na chemotherapy cyangwa izindi miti yibanda, bitewe n'imiterere yihariye ya kanseri yawe.

Chemotherapy gakondo iracyari uburyo bw'ingenzi, cyane cyane ku barwayi kanseri zabo zitagira mutations zishobora kwibandwaho cyangwa zateje ubwivumbagatanye ku buvuzi bwinshi bwibanda. Muganga wawe w'inzobere mu by'indwara z'umubiri azagufasha kumenya urutonde rwiza rw'ubuvuzi ku miterere yawe yihariye.

Ese Osimertinib iruta Erlotinib?

Osimertinib na erlotinib zombi zikoreshwa neza mu guhagarika EGFR, ariko zikora neza mu bihe bitandukanye. Osimertinib akenshi ifatwa nk'iyo ikora neza mu kuvura kanseri y'ibihaha yatewe na EGFR mu murongo wa mbere kandi yagaragaje ibisubizo byiza mu igeragezwa ryo kwa muganga.

Ubushakashatsi bwagaragaje ko osimertinib akenshi itanga igihe kirekire cyo kubaho nta ndwara ugereranije na erlotinib iyo ikoreshwa nk'urugero rwa mbere. Ibi bivuze ko abarwayi akenshi bamara igihe kirekire mbere y'uko kanseri yabo itangira kongera gukura iyo bavurwa na osimertinib mbere.

Osimertinib kandi ifite ubushobozi bwo kwinjira mu bwonko, bituma ikora neza mu gukumira cyangwa kuvura metastases mu bwonko. Ibi ni ngombwa cyane kuko kanseri y'ibihaha ikunda gukwirakwira mu bwonko.

Ariko, erlotinib irashobora gukundwa mu bihe bimwe na bimwe, nk'igihe ikiguzi ari ikintu gikomeye cyangwa igihe umurwayi afite ingaruka zidasanzwe zituma osimertinib idakwiriye. Muganga wawe azatekereza ibi bintu byose mugihe asaba uburyo bwiza bwo kuvura ikibazo cyawe.

Ibikunze Kubazwa Kuri Osimertinib

Ese Osimertinib irakwiriye abantu barwaye indwara z'umutima?

Osimertinib irashobora gukoreshwa kubantu barwaye indwara z'umutima, ariko bisaba gukurikiranwa neza kandi birashoboka ko imiti ihindurwa. Umuti rimwe na rimwe ushobora kugira ingaruka kumutima cyangwa imikorere yawo, bityo muganga wawe azasuzuma ubuzima bwumutima wawe mbere yo gutangira kuvurwa.

Niba ufite amateka y'ibibazo by'umutima, muganga wawe ashobora gutumiza ibizamini by'umutima byibanze, harimo electrocardiogram (ECG) ndetse no gushobora echocardiogram. Ibi bizamini bifasha kumenya imikorere y'umutima wawe ubu kandi bitanga ishingiro ryo gukurikiranwa mugihe cyo kuvurwa.

Mugihe cyo kuvurwa, uzagira ibizamini bya buri gihe kugirango ukurikirane imikorere y'umutima wawe. Niba hari ingaruka zerekeye umutima zigaragara, muganga wawe ashobora guhindura urugero rwawe cyangwa gutanga izindi miti kugirango arinde umutima wawe mugihe akomeza kuvura kanseri yawe.

Ninkora iki niramuka nfashe Osimertinib nyinshi ku buryo butunguranye?

Niramuka ufata osimertinib nyinshi ku buryo butunguranye kurusha uko byagutegetswe, vugana n'umuganga wawe cyangwa ikigo gishinzwe ubumara ako kanya. Ntuzategereze ngo urebe niba ibimenyetso bigaragara, kuko kubona inama z'ubuvuzi vuba bifite akamaro ku mutekano wawe.

Kunywa osimertinib nyinshi bishobora kongera ibyago byo kugira ingaruka zikomeye, cyane cyane izo zireba umutima wawe, ibihaha, cyangwa uruhu rwawe. Abaganga bashobora kugukurikiranira hafi kandi bakaguha ubufasha niba bikenewe.

Zana urupapuro rw'imiti yawe niba ukeneye kujya kwa muganga, kuko ibi bifasha abaganga gusobanukirwa neza icyo wafashe n'ingano yacyo. Ntukagerageze na rimwe "kwishyura" kubera urugero rwinshi rwa imiti ukoresheje kwirengagiza doze zizaza.

Ninkora iki niramuka nirengagije doze ya Osimertinib?

Niramuka wirengagije doze ya osimertinib, yifate ako kanya wibuka, keretse igihe cyegereye doze yawe itaha iteganyijwe. Mur'icyo gihe, irengagize doze yirengagijwe ukomeze gahunda yawe isanzwe.

Ntuzigere ufata doze ebyiri icyarimwe kugirango wishyure doze yirengagijwe, kuko ibi bishobora kongera ibyago byo kugira ingaruka ziterwa n'imiti. Niba utazi neza igihe, vugana n'umuganga wawe cyangwa umufarumasiti kugirango baguhe ubuyobozi.

Kugirango wibuke doze yawe ya buri munsi, tekereza gushyiraho alarume ya terefone cyangwa ukoreshe umuteguro w'ibinini. Gufata imiti yawe ku gihe kimwe buri munsi bifasha kubungabunga urwego ruringaniye mu mubiri wawe kandi bigateza imbere imikorere y'ubuvuzi.

Nshobora guhagarika ryari gufata Osimertinib?

Ugomba guhagarika gufata osimertinib gusa ukurikije ubuyobozi bw'umuganga wawe w'inzobere mu kuvura kanseri. Umwanzuro wo guhagarika ubuvuzi ushingiye ku bintu bitandukanye, harimo uburyo imiti igenzura kanseri yawe n'uburyo wihanganira ingaruka zose.

Muganga wawe azakoresha ibizamini bisanzwe no gupima amaraso kugira ngo akurikirane uko kanseri yawe yitwara ku buvuzi. Niba ibizamini byerekana ko kanseri yawe ikura nubwo uvurwa, cyangwa niba ugize ingaruka zikomeye zitashobora gucungwa, muganga wawe ashobora kugusaba guhagarika osimertinib.

Abantu bamwe bakomeza gufata osimertinib imyaka myinshi niba ifasha mu kugenzura kanseri yabo hamwe n'ingaruka zicungwa neza. Abandi bashobora gukenera guhindura uburyo bwo kuvurwa butandukanye niba kanseri yabo igize ubwihishamo cyangwa niba ingaruka ziba zikomeye cyane.

Nshobora kunywa inzoga nkanwa Osimertinib?

Nta mikoranire yihariye iri hagati ya osimertinib n'inzoga, ariko muri rusange birasabwa kugabanya kunywa inzoga mugihe cyo kuvurwa kanseri. Inzoga irashobora gutuma ingaruka zimwe na zimwe zirushaho kuba mbi nko gucika intege, isesemi, n'ibibazo byo mu gifu.

Niba uhisemo kunywa inzoga rimwe na rimwe, bikore mu rugero kandi witondere uko umubiri wawe witwara. Abantu bamwe basanga inzoga zibagiraho ingaruka cyane mugihe bavurwa kanseri, kabone niyo ari ntoya.

Buri gihe ganira ku kunywa inzoga n'ikipe yawe y'ubuzima, cyane cyane niba ufata indi miti hamwe na osimertinib. Bashobora gutanga inama zihariye zishingiye ku gahunda yawe yuzuye yo kuvurwa n'ubuzima bwawe muri rusange.